IRVINE, Calif., July 21 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will release second quarter 2010 financial results after market on August 4, 2010. In conjunction, the Company will host a conference call at 4:30 p.m. Eastern Time focusing on its commercial results, legal and regulatory updates and pipeline progress. There will be a change in the Company’s historic conference call format, as management will now conduct a question and answer session after each of the three sets of formal comments.
Date: Wednesday, August 4, 2010 | |
Time: 4:30 p.m. Eastern Time | |
Conference call access: | |
Internet: www.istavision.com | |
Domestic dial-in: 866-383-7989 | |
International dial-in: 617-597-5328 | |
Passcode: 26928422 | |
To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 88876440. This conference call also will be webcast live and archived on ISTA’s website until September 4, 2010.
About ISTA Pharmaceuticals
ISTA Pharmaceuticals, Inc. is the fourth largest and fastest growing branded prescription eye care business in the United States, with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The Company’s development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain and nasal allergies. Headquartered in Irvine, California, the Company generated 2009 revenues of $111 million. For additional information about ISTA Pharmaceuticals, please visit the corporate website at www.istavision.com.
SOURCE ISTA Pharmaceuticals, Inc.
